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 CURRENTOPINION Asthma, allergy and the Olympics: a 12-year survey
in elite athletes
Matteo Boninia,b, Claudia Gramiccioni b,c, Daniela Fioretti b, Beate Ruckertd,
Monica Rinaldib, Cezmi Akdisd, Antonio Todaroe, Paolo Palangea,
Kai-Hakon Carlsenf, Antonio Pellicciae, Guido Rasi g, Sergio Boninib,h,
on behalf of the AIDA and the Italian Unit of the GA2LEN Olympic Study
Objective
There are no comprehensive surveys relating the reported high prevalence of asthma and allergic diseases
in athletes to comorbidities and immune changes associated with intense chronic exercise. This 12-year
survey aims to evaluate several clinical, functional and immunological parameters in order to assess
features, trend and burden of asthma, allergy, infections and autoimmune diseases, in a large
homogeneous population of Olympic athletes.
Methods
Six hundred and fifty-nine Italian Olympic athletes were studied through four cross-sectional surveys
performed between 2000 and 2012 before the Summer and Winter Olympics. Clinical diagnosis of
allergic, autoimmune and infectious diseases was complemented by: skin-prick tests (n¼569); pulmonary
function tests (n¼415); total (n¼158) and specific (n¼72) serum IgE; serum autoantibodies (n¼30),
cytokines and growth factors (n¼92); flow cytometry (n¼135).
Results
The prevalence of asthma and/or exercise-induced bronchoconstriction was 14.7%, with a significant
increase (P¼0.04) from 2000 (11.3%) to 2008 (17.2%). The prevalence of rhinitis, conjunctivitis, skin
allergic diseases and anaphylaxis was 26.2%, 20.0%, 14.8% and 1.1%, respectively. Sensitization to
inhalant allergens was documented in 49.0% of athletes, being 32.7% in 2000 and 56.5% in 2008
(P<0.0001). Food, drug and venom allergy was present in 7.1%, 5.0% and 2.1% of athletes,
respectively. The high prevalence of asthma and allergy was associated with recurrent upper respiratory
tract (10.3%) and herpes (18.2%) infections, an abnormal T cell subset profile and a general down-
regulation of serum cytokines with a significantly lower IFN-g/IL-4 ratio.
Conclusion
A chronic and intense physical exercise may cause a transient immunodepression with a preferential shift
to a Th2 response, associated with abnormalities of the respiratory tract.
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INTRODUCTION
Several studies [1–3] called attention to a high
prevalence of asthma in athletes, ranging from
22.8 to 54.8% depending on the type of sport dis-
cipline and on criteria used for diagnosis. However,
independently from the above potential confound-
ers, studies performed inOlympic teams before 2000
show that the prevalence of asthma in elite athletes
is high and increasing, from 9.7% in 1976 to 21.9%
in 1996 in the Australian Olympic delegation [4,5],
and from 11.2% in 1984 to 16.7% in 1996 in the US
Olympic delegation [6,7]. Asthma in elite athletes
appears to be a distinct phenotype [8–12] which
needs adequate attention and management consid-
ering that 23.1% of the 263 sudden deaths in
athletes reported by Becker et al. [13] occurred in
asthmatic athletes.
In addition to the high prevalence of asthma
and airway hyperresponsiveness, an increased
reported risk of upper respiratory tract infections
(URTIs) has been reported in elite athletes [14,15].
Both viruses (rhinovirus, influenza and para-
influenza viruses, adenovirus and coronavirus)
and bacteria (streptococci and staphylococci) are
claimed to be involved in causing URTI in athletes,
although data from large systematic studies includ-
ing the isolation and identification of the respon-
sible agents are still very limited.
Although URTIs have been shown to be fol-
lowed by wheezing in athletes [16], allergy is con-
sidered to be the major risk factor for asthma in this
population. In fact, the risk of asthma increases
25-fold in atopic speed and power athletes, 42-fold
in atopic long-distance runners and 97-fold in
atopic swimmers [17].
As for asthma, sensitization to common aller-
gens and allergic diseases has been reported to have
a high and increasing prevalence in elite athletes
[18–20]. Allergic rhinitis has been documented in
16.8 [18] to 29.5% [5] of athletes, affecting their
performances and quality of life [21]. Moreover,
prospective studies in the general population
indicate that rhinitis frequently precedes the onset
of asthma representing a risk factor for it [22]. Aller-
gic skin diseases are also often observed, favored by
several factors related to exercise, as well as by con-
tact with sport materials and instruments (warming
or cooling, sweating, sun exposure, pressure, rubber
vests, etc.) [23]. At last, exercise-induced anaphy-
laxis, a life-threatening condition, has been reported
in this peculiar population often in relation to
ingestion of food a few hours before exercising [24].
In contrast to the numerous reports on asthma
and allergy in athletes, data on the prevalence of
autoimmune diseases and circulating autoanti-
bodies in this peculiar population are scarce,
although some clinical pictures reported with a
higher prevalence in athletes, such as amyotrophic
lateral sclerosis (Gehrig disease), have been referred
to autoimmune phenomena [25].
The mechanisms underlying the epidemiologi-
cal evidence of a close relationship between intense
exercise and asthma and/or immune diseases are not
fully elucidated. In fact, although an acute exercise
challenge has been shown to represent a stress event
inducing several immunological changes, few data
are available on the effects of intense and chronic
exercising on the immune system [26].
Olympic athletes represent a unique model
of regular intense physical training undergoing
increasing loads of work in the period preceding
the Games.
This 12-year study aims to evaluate several
clinical, functional and immunological parameters
in order to assess features, trend and burden of
asthma, allergy, infections and autoimmune dis-
eases, in a large homogeneous population of
Olympic athletes studied with the same method-
ologies in four cross-sectional surveys performed on
the occasions of the Sydney (2000), Beijing (2008),
Vancouver (2010) and London (2012) Olympics.
This comprehensive approach also might help to
generate hypothesis on the possible effects of an
intense and chronic physical exercise in health
or disease.
METHODS
Study design
In 659 athletes selected to be a part of the Italian
Olympic Delegation at Summer (Sydney 2000,
Beijing 2008 and London 2012) and Winter
(Vancouver 2010) Olympics, clinical data were
collected through history taking, standardized vali-
dated questionnaires [27] andmedical examination,
with special reference to the presence of sensitiz-
ation and allergic diseases, asthma, URTI and auto-
immune diseases.
The following clinical, functional and immuno-
logical parameters were also collected, depending
on athlete and sample availability with no pre-
planned clinical selection criteria, in order to answer
specific epidemiological and mechanistic study
questions:
(1) Skin test reactivity to common allergens
(n¼569)
(2) Pulmonary function tests (n¼415)
(3) Total serum IgE determination (n¼158)
(4) Specific serum IgE determination (n¼72)
(5) Serum autoantibodies (n¼30)
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(6) Flow cytometry (n¼135)
(7) Serum cytokine and growth factor levels (n¼92)
The same diagnostic criteria and procedures
were adopted on the occasion of all surveys.
Study population
Sixhundred and fifty-nine athletes (sex 441men, 218
women, age range 16–40, mean 27.05.5 years)
were studied. The 30 sport disciplines practiced were
grouped according to standard classifications based
on environmental exposure, metabolic pathways
and cardiovascular risk (Table 1).
Data were collected in distinct cross-sectional
studies, performedwithin6monthsbefore theOlym-
pic Games, during an intense training period. The
Sydney and Beijing surveys performed in a wide
population of athletes were mainly aimed at evaluat-
ing the changing prevalence of asthma and allergy 8
years apart. Smaller population samples were studied
in Vancouver to evaluate differences, if any, between
summer and winter sports and in London to assess
intraindividual variability of pulmonary function
and compliance to the treatment of the asthmatic
athletes already included in the Beijing survey.
Informed written consent was obtained by all
athletes. Data were treated in respect of privacy and
ethical requirements. The study was approved by
the Internal Review Board of the Italian National
Olympic Committee.
Study procedures
Study procedures are reported in detail in the
online repository material (Supplemental Digital
Content 1, http://links.lww.com/COAI/A12).
Diagnostic criteria
Diagnosis of asthma and degree of disease control
weremade according to Global Initiative for Asthma
(GINA) guidelines (www.ginasthma.org) on the
basis of a comprehensive evaluation of history,
questionnaires, medical examination, pulmonary
function tests and bronchial challenges. Athletes
with exercise-induced bronchoconstriction (EIB)
were considered as asthmatic patients even in the
absence of clinical asthma.
Rhinitis, conjunctivitis, allergic skin diseases,
anaphylaxis and autoimmune diseases were diag-
nosed according to standard clinical criteria and
international and national guidelines for these dis-
eases, with special reference to criteria set for ath-
letes [3,19,28]. Athletes were defined as allergic in
the presence of at least one positive sensitization to
allergens at skin tests.
URTI and herpes infections were diagnosed on
the basis of clinical criteria without identification
and isolation of the responsible agents.
Statistical analysis
Statistical analysis was done using parametric or
nonparametric tests, depending on the data distri-
bution of the variables under study, through the
SPSS19 software (IBM, Armonk, New York, USA).
P values <0.05 were considered as significant.
Table 1. Sport disciplines and categories
Sport disciplines Number of athletes
Archery 3
Athletics 55
Baseball 54
Basketball 22
Boxing 12
Canoe/Kayak 53
Cycling 46
Equestrian 19
Fencing 28
Field hockey 11
Figure skating 7
Football 25
Golf 5
Gymnastics 22
Judo 32
Modern pentathlon 3
Rowing 52
Sailing 16
Shooting 37
Skiing 15
Swimming 16
Table tennis 5
Taekwondo 7
Tennis 31
Triathlon 1
Volleyball (beach) 17
Volleyball (indoor) 31
Water polo 21
Weightlifting 5
Wrestling 8
Total 659
Sport categories
Outdoor/indoor 443/216
Aerobic/anaerobic/mixed 234/209/216
Low/high cardiovascular risk 50/609
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RESULTS
Asthma and allergy in Olympic athletes
The prevalence of asthma in the 659 athletes studied
was 14.7% (Fig. 1). In the 97 athletes defined as
asthmatic patients, a previous doctor diagnosis of
asthma was made in 61.9% of cases, whereas 81.7%
referred respiratory symptoms suggestive of clinical
asthma. Asthma appeared not to be under control in
18.6% of athletes; however, only half of them were
using antiasthmatic drugs at the time of obser-
vation. EIB was present in 8.1% of athletes, being
associated with clinical asthma in 64.8% of cases.
Mean values of forced expiratory volume in the
1st second (FEV1) (107.713.3% of predicted) and
forced expiratory flow (FEF)25–75 (95.221.4% of
predicted) in asthmatic athletes were not signifi-
cantly different from those of healthy athletes
(108.612.8% and 96.321.9%, respectively).
Furthermore, 68.2% of asthmatics athletes had
FEV1 values more than 100% of predicted, whereas
only 7.2 and 14.0% had abnormal FEV1 (less than
80% of predicted) and FEF25–75 (less than 70% of
predicted) values, respectively.
A positive bronchodilator test was observed only
in athletes with clinical asthma and abnormal FEV1
basal values at the time of testing. At least one
positive bronchoprovocative challenge for docu-
menting EIB was found in 75.0% of the athletes
tested (those with a suspected diagnosis and FEV1
greater than 80%), independently from the presence
of clinical asthma. Pulmonary function data col-
lected in athletes who took part in both the Beijing
and London Olympics, in spite of nonclinically
relevant intraindividual variability overtime, did
not show any significant difference between the
two surveys.
The prevalence of rhinitis, conjunctivitis, skin
allergic diseases and anaphylaxis was 26.2, 20.0,
14.8 and 1.1%, respectively. In 31.1% of athletes,
two or more allergic diseases were present (Fig. 1).
Sensitization to at least one inhalant allergen
was documented by skin tests in 49.0% of the 569
athletes tested. Dermatophagoides (35.0%), grass
(25.0%) and Parietaria (14.7%) represented the aller-
gens more frequently responsible for sensitization
(Fig. 2); 79.0% of skin-positive athletes had more
than one sensitization.
The type of sport disciplines and categories did
not significantly influence the prevalence and pat-
tern of sensitization or allergic disease. However, a
reliablemultivariate analysis was not possible due to
the low number of athletes in homogeneous sub-
groups defined by taking into account the sport
categories in each sport discipline.
Food, drug and venom allergy was present in
7.1, 5.0 and 2.1% of athletes, respectively. Three out
of the seven cases of anaphylaxis were associated
with food allergy.
When data on disease and allergy werematched,
a clinically relevant sensitizationwas present in over
two-thirds of the symptomatic athletes. In particu-
lar, asthma was shown to have an allergic origin in
85.1% of cases.
The comparison of asthma and allergy preva-
lence rates between the Sydney and BeijingOlympics
(Table 2) showed a consistent increase for all clinical
phenotypes, which was significant for asthma
(P¼0.049), allergic skin diseases (P¼0.018) and sen-
sitization (P¼0.0001). On the contrary, there were
no differences in the relative prevalence of allergens
causing sensitization, although the number of poly-
sensitized athletes increased from 62.5% in 2000 to
85.0% in 2008.
Only 23.8% of allergic symptomatic athletes
had ever received antiallergic/antiasthmatic treat-
ment. On the contrary, a high proportion of athletes
(34.1%) had received supplements and drugs
80
70
50
60
30
40
20
10
0
De
rm
ato
ph
ag
oid
es
Gr
as
s
Pa
rie
tar
ia
At 
lea
st 
two
 se
ns
itiz
ati
on
s
%
FIGURE 2. Relative prevalence of sensitization to main
inhalant allergens at skin tests in the 569 Olympic athletes.
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bronchoconstriction.
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(mainly nonsteroid anti-inflammatory drugs) in the
week before examination. Six of the seven asthmatic
athletes, who participated in both the Beijing and
London Olympics, showed a very poor compliance
to the treatment prescribed according to GINA
guidelines and in respect of the World Anti-Doping
Agency (WADA) regulation. Data on smoking habits
available in 378 athletes showed a prevalence of
smokers in 18%.
The prevalence of asthma and allergy was not
significantly different between pre-Olympic athletes
whoqualified for theGamesand thosewhocouldnot
qualify. Six medals out of the 23 obtained by the
Italian athletes studied were won by allergic/asth-
matic athletes.
Infections and autoimmunity in Olympic
athletes
The prevalence of recurrent infections was particu-
larly high in athletes, although the lack of data from
a matched general population prevents understand-
ing the magnitude and relevance of this finding;
10.3% of athletes had more than three URTI and
18.2% of athletes had more than one relapse of
herpes infection in the last 12 months. The pre-
valence of URTI was not significantly different
between Sydney 2000 and Beijing 2008.
No clinical autoimmune disease was present in
any of the athletes studied. The presence of autoanti-
bodies of potential clinical relevance, tested in a pilot
study (n¼30 athletes), was only found in two appa-
rently healthy young female athletes (very high titers
of thyroid peroxidase antibodies in one case and a
homogeneous immunofluorescence pattern of anti-
nuclear antibodies, associated with border-line titers
of anti-centromere antibodies in the other case).
Immunological profile in Olympic athletes
Total serum IgEs were significantly higher in allergic
than in nonallergic athletes (median values
105 kU/l; CI 95% 83.0–160.0 kU/l vs 38 kU/l;
27.4–50.5 kU/l; P¼<0.05). However, both allergic
and nonallergic athletes had total serum IgE values
within the range reported in a sedentary matched
sample of the Italian general population.
In 16.0% of polysensitized asthmatic athletes,
specific IgE to molecular allergen components were
directed against cross-reacting allergens (profilins,
PR-10). Allergens at risk for severe allergic reactions
(Ara h 1,2,3; Pru p 3; Cor a 8; omega-5 gliadin) were
furthermore detected in 6.0% of all polysensitized
athletes tested, even in the absence of clinical symp-
toms.
Mean values of circulating leukocyte subsets
identifiable by flow cytometry with the panel of
monoclonal antibodies used were within the
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normal levels. However, abnormal values were
recorded in individual cases: 43.7% of the 135 ath-
letes studied had increased circulating basophils and
11.1% increased circulating eosinophils. A reduced
absolute number of CD3þ cells and natural killer
cells were found in individuals, often associated
with URTI and recurrences of herpes labialis infec-
tions. The ratio between CD4þ cells and CD8þ cells
was increased in 20.7% of athletes. However, no
clear-cut correlation was found between any
single-cell subset abnormality and the clinical status
(allergy and/or susceptibility to infections).
Serum levels of all cytokines and growth factors
measured (Table 3) – except IL-13, macrophage
inflammatory protein-1 alfa (MIP-1alfa) and TNFa
– were significantly lower in athletes than in the 49
healthy sedentary matched controls (P<0.05). This
downregulation was particularly significant for IL-
1ra, IL-8, IL-12, PCP-1, IFN-g, platelet-derived
growth factor and vascular endothelial growth fac-
tor (P<0.0001). No difference was observed
between allergic and nonallergic athletes, except
for G-CFS which was significantly lower in allergic
athletes (P<0.01). The median value of the IFN-g/
IL-4 ratio was significantly lower (P¼0.03) in aller-
gic athletes (27.8) than in both nonallergic athletes
and controls (37.7 and 39.0, respectively).
DISCUSSION
This 12-year study provides data on the prevalence
of allergic diseases in relation to comorbidities and
immune changes, in one of the largest population of
Olympic athletes ever studied.
The prevalence of asthma appears to be high
(14.7%) and significantly increased from 11.3% in
2000 to 17.2% in 2008 in Summer Italian Olympic
athletes. This finding has been previously reported
in studies performed before 2000 in other national
Olympic delegations [3,5–8]. However, the use of
the same study protocol and methodology in differ-
ent cross-sectional surveys allows us to more accu-
rately evaluate the increasing trend of this morbid
condition, as well as to provide updated information
in a large population of athletes. Our study did not
include a control group. However, large epidemio-
logical studies performed in Italy in a matched
sedentary population sample reported a prevalence
of asthma ranging from 3.3 to 7.1% and only
increasing from 4.6% in 1997–2000 to 6.6% in
2007–2010 [29].
Epidemiological data and evidence emerging
from the clinical, functional and immunological
variables studied may also suggest mechanisms
which contribute to the complex relationships
between physical activity and health or disease.
A possible reason for the high prevalence of
asthma found in our study might be related to the
criteria used for the diagnosis and the complex
relationships between asthma and EIB. The diagno-
sis of asthma in this study, following the criteria
requested by the IOC to permit the use of b2-ago-
nists in Beijing, included among asthmatic athletes
also athletes with no clinical history of asthma but
with airway hyperresponsiveness after various bron-
chial challenges. In fact, EIB may occur both in
athletes with asthma not under control and in ath-
letes without clinical asthma [10]. EIB in athletes
without clinical asthma accounted for about 20% of
athletes diagnosed as asthmatic patients. However,
even after excluding the cases with EIB only (19/97),
the prevalence of asthma remains still high (11.8%).
Asthma and/or EIB are reportedmore frequently
in some sports (such as endurance disciplines, swim-
ming and winter sports) that expose athletes to an
increased ventilation in particular environmental
conditions (presence of allergens and pollutants,
chlorine, cold air, etc.) [3]. This finding, however,
could not be confirmed in our study. The prevalence
of asthma in swimmers or in athletes participating
in the Winter Vancouver Olympics was, in fact, not
significantly different from that of summer athletes.
However, the limited number of athletes in each
sport discipline does not allow disproving of data
previously reported in larger population samples.
A possible second reason for the high prevalence
of asthma in our Olympic delegation is the higher
prevalence of allergy, a well known risk factor for
asthma development [17]. The prevalence of a sen-
sitization to at least one allergen at skin tests was
found in almost 50% of athletes. This very high
sensitization rate was also associated with a higher
prevalence of other allergic diseases, such as allergic
rhinitis, conjunctivitis and skin diseases (one athlete
out of three suffering from one or more allergic
diseases).
Interestingly, suffering from asthma and allergy
did not affect the quality of performances and the
chance of qualifying for the Olympics or winning a
medal. In fact, there was no statistically significant
difference in the prevalence of asthma and allergy
between athletes who qualified for the Olympics and
those who did not qualify; furthermore, out of the
26medalswon inBeijingby24of the ItalianOlympic
athletes studied, eight were won by allergic athletes
(two with asthma). This confirms that asthmatic
athletes and allergic athletes may compete at the
highest level if adequately diagnosed and treated
[30].
As for asthma, the prevalence of allergy signifi-
cantly increased from 2000 to 2008, with a very high
rate of polysensitized athletes in more recent years.
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Because the relative prevalence of specific sensitiz-
ations was similar to that of the general population
and no difference was observed in relation to
environmental exposure (indoor vs outdoor disci-
plines), the high sensitization rate in athletes does
not appear to be related to specific sport allergens
but rather to an effect of chronic and intense exer-
cise on a polyclonal IgE response.
The above clinical findings and the immuno-
logical data presented may allow a comprehensive
interpretation of the effect of chronic and intense
physical activity in elite athletes.
Our Olympic athletes showed a high prevalence
of sensitization associated with increased serum
total and specific IgE and circulating basophils
and eosinophils, as well as a high prevalence of
mucosal infections, often associated with an abnor-
mal T-cell profile and a general downregulation of
most of the cytokines tested with a low IFN-g/IL-4
ratio. On the contrary, no evidence of clinical
autoimmune diseases or increased circulating auto-
antibodies was found. These findingsmight confirm
the hypothesis that chronic and intense physical
exercise may affect the Treg/Th1/Th2 balance with
a preferential shift to a Th2 immune response
[31–33]. However, the higher prevalence of asthma
and rhinitis in athletes may certainly recognize
additional factors, which affect target organs inde-
pendently from their effects on the immune func-
tion such as those reported for asthma and related to
hyperventilation with a bypass of the nasal filter.
Therefore, although a moderate physical
activity has been shown to represent a beneficial
lifestyle factor for maintaining health and prevent-
ing obesity and chronic inflammatory diseases [34],
excessive training may represent a stress event with
potential negative influences on the immune
response that should be adequately monitored
and prevented.
Our findings may also reflect some practical
implications for the management of elite athletes
and, in general, of all exercisers at competitive and
noncompetitive levels.
Firstly, medical examination of competitive
exercisers and elite athletes is at present confined –
as far as it concerns allergic diseases – to physical
examination and baseline pulmonary function
tests, which in this study and in our experience
[35] was shown to have a very limited predictive
value. Data presented indicate that asthma is often
underdiagnosed (only 61.9% of athletes had a
previous doctor’s diagnosis of asthma) and very
often undertreated (only half of the 18.6% of ath-
letes with asthma not under control were receiving
treatment). Furthermore, although allergy was
shown to be a major risk factor for asthma [17]
and present in 85.1% of our asthmatic athletes,
allergy diagnostics is not a part of the routinemedical
examination. Specific questionnaires for athletes,
such as the Allergy Questionnaire for Athletes
(AQUA) [27] used in our study, may help in iden-
tifying athletes with clinical or subclinical allergy
and bronchial hyperresponsiveness after exercise
in spite of normal spirometric values, to be even-
tually submitted to further appropriate investi-
gations.
With reference to the relevance of allergy testing
in athletes, it should also be noted that food allergy
was present in 7.1% of our athletes, not infrequently
associated with anaphylaxis. Therefore, com-
ponent-resolved diagnosis of specific or cross-react-
ing allergens may be very helpful in polysensitized
athletes for diagnosing food allergy and preventing
severe asthma and anaphylaxis [36].
It must be also noted that the occurrence of
asthma exacerbations, URTI and allergy symptoms
at the time of competition, apart from affecting
athletes’ health, may significantly impair their per-
formances. Monitoring of asthma control should
therefore be mandatory, as well as standardized
immunological markers should be defined to plan
training programs and avoid the transient immune
imbalance associated with overtraining. Preventive
measures should also include a vigorous campaign
for cessation of smoking, which was a frequent habit
in our study, unexpected for an elite sport popu-
lation and regretfully observed even in asthmatic
athletes.
At last, our study indicates that although over-
medication is a common practice in athletes, only a
small proportion of those with asthma and/or
allergy (almost one athlete out of four) have ever
received an antiasthmatic/antiallergic treatment,
very often not in agreement with the International
Guidelines. Furthermore compliance to treatment
in our study was shown to be very poor. First-gener-
ation antihistamines, often used, not only affect
vigilance and physical performances but may
represent a danger for their potential cardiovascular
side-effects. It is also unexpected that long-acting
beta-2 agonists (LABAs), in contrast to Food and
Drug Administration-European Medicines Agency
warnings [37] and in view of the reported onset
of tolerance [38,39], were often used in our
athletes to prevent EIB without the concomitant
use of inhaled steroids. The use of b-2 agonists
as monotherapy was still reported in 25% of
athletes applying for their use in the 2010
Olympics [9].
In conclusion, our data indicate that intense
and chronic exercise is associated, in Olympic
athletes, with a higher prevalence of asthma, airway
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hyperresponsiveness, allergic sensitizations and
infections, as well as with immune changes sugges-
tive of a Th2 phenotype. These findings should call
for adequate medical, environmental and logistic
policies on the occasion of the future Olympic
Games. They might also provide useful practical
hints for better management of the many competi-
tive and noncompetitive exercisers with asthma
and allergy.
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